These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 27548625)
1. Update on the effects of treatment with recombinant tissue-type plasminogen activator (rt-PA) in acute ischemic stroke. Bonaventura A; Montecucco F; Dallegri F Expert Opin Biol Ther; 2016 Nov; 16(11):1323-1340. PubMed ID: 27548625 [TBL] [Abstract][Full Text] [Related]
2. Thrombolytics in acute ischaemic stroke: historical perspective and future opportunities. Röther J; Ford GA; Thijs VN Cerebrovasc Dis; 2013; 35(4):313-9. PubMed ID: 23615379 [TBL] [Abstract][Full Text] [Related]
3. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment. Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS; Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995 [TBL] [Abstract][Full Text] [Related]
4. Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era. Endo K; Koga M; Sakai N; Yamagami H; Furui E; Matsumoto Y; Shiokawa Y; Yoshimura S; Okada Y; Nakagawara J; Hyogo T; Hasegawa Y; Nagashima H; Fujinaka T; Hyodo A; Terada T; Toyoda K; J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):805-10. PubMed ID: 22721823 [TBL] [Abstract][Full Text] [Related]
6. The molecular basis of thrombolysis and its clinical application in stroke. Murray V; Norrving B; Sandercock PA; Terént A; Wardlaw JM; Wester P J Intern Med; 2010 Feb; 267(2):191-208. PubMed ID: 20175866 [TBL] [Abstract][Full Text] [Related]
7. Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator. Pfeilschifter W; Kashefiolasl S; Lauer A; Steinmetz H; Foerch C Neuroscience; 2013 Oct; 250():181-8. PubMed ID: 23856067 [TBL] [Abstract][Full Text] [Related]
8. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes. Williams JM; Navin TJ; Jude MR; Levi CR Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520 [TBL] [Abstract][Full Text] [Related]
9. [Prospects of thrombolytic therapy for acute ischemic stroke]. Nakashima T; Minematsu K Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399 [TBL] [Abstract][Full Text] [Related]
10. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China. Yan X; Hu HT; Liu S; Sun YH; Gao X Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471 [TBL] [Abstract][Full Text] [Related]